Canada markets open in 6 hours 28 minutes
  • S&P/TSX

    20,164.39
    -36.26 (-0.18%)
     
  • S&P 500

    4,241.84
    -4.60 (-0.11%)
     
  • DOW

    33,874.24
    -71.34 (-0.21%)
     
  • CAD/USD

    0.8129
    +0.0004 (+0.04%)
     
  • CRUDE OIL

    73.42
    +0.34 (+0.47%)
     
  • BTC-CAD

    40,631.99
    -1,296.45 (-3.09%)
     
  • CMC Crypto 200

    797.79
    -12.40 (-1.53%)
     
  • GOLD FUTURES

    1,777.30
    -6.10 (-0.34%)
     
  • RUSSELL 2000

    2,303.47
    +7.52 (+0.33%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • NASDAQ futures

    14,298.75
    +35.75 (+0.25%)
     
  • VOLATILITY

    16.32
    -0.34 (-2.04%)
     
  • FTSE

    7,074.06
    0.00 (0.00%)
     
  • NIKKEI 225

    28,875.23
    +0.34 (+0.00%)
     
  • CAD/EUR

    0.6809
    0.0000 (0.00%)
     

Global Acute Myeloid Leukemia Markets, Epidemiology and Patient Flow Report 2020-2035 - ResearchAndMarkets.com

·2 min read

The "Global Acute Myeloid Leukemia Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2021, provides Acute Myeloid Leukemia epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Acute Myeloid Leukemia patients, history of the disease at the population level (Acute Myeloid Leukemia prevalence, Acute Myeloid Leukemia incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Acute Myeloid Leukemia patient flow: Acute Myeloid Leukemia prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Acute Myeloid Leukemia patients by age group, gender

  • Forecast: Acute Myeloid Leukemia epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Acute Myeloid Leukemia market sizing, assessing market potential, and developing drug forecast models

  • Identify Acute Myeloid Leukemia patients segments through age groups, gender, and disease sub-types

  • Develop Acute Myeloid Leukemia population-based health management frameworks

  • Evaluate Acute Myeloid Leukemia market opportunities, identify target patient population

  • Align marketing decisions with the Acute Myeloid Leukemia target population

  • Communicate leadership and health authorities about your Acute Myeloid Leukemia target patient population

Key Topics Covered:

1. Research Methodology

2. Acute Myeloid Leukemia Patients Definition

3. US Acute Myeloid Leukemia Epidemiology and Patient Flow

4. Germany Acute Myeloid Leukemia Epidemiology and Patient Flow

5. France Acute Myeloid Leukemia Epidemiology and Patient Flow

6. Italy Acute Myeloid Leukemia Epidemiology and Patient Flow

7. Spain Acute Myeloid Leukemia Epidemiology and Patient Flow

8. UK Acute Myeloid Leukemia Epidemiology and Patient Flow

9. Europe Acute Myeloid Leukemia Epidemiology and Patient Flow

10. Japan Acute Myeloid Leukemia Epidemiology and Patient Flow

11. Global Acute Myeloid Leukemia Epidemiology and Patient Flow

For more information about this report visit https://www.researchandmarkets.com/r/a2tysp

View source version on businesswire.com: https://www.businesswire.com/news/home/20210512005835/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting